CanadaBis Capital Inc (CANB) - Cash Flow Conversion Efficiency

Latest as of October 2025: 0.056x

Based on the latest financial reports, CanadaBis Capital Inc (CANB) has a cash flow conversion efficiency ratio of 0.056x as of October 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$437.61K ≈ $316.56K USD) by net assets (CA$7.80 Million ≈ $5.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CANB market cap for the company's overall valuation and market capitalisation.

CanadaBis Capital Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how CanadaBis Capital Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CanadaBis Capital Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CanadaBis Capital Inc ranked by their cash flow conversion efficiency. Explore CanadaBis Capital Inc cash earnings quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Strategic Equity Capital Closed Fund LSE:SEC	0.001x
Phoenix Spree Deutschland Ltd LSE:PSDL	0.012x
Jet.AI Inc. NASDAQ:JTAI	0.031x
INVO Fertility, Inc. NASDAQ:IVF	-0.304x
GEMINA LABS LTD F:8I7	-0.007x
Bohra Industries Limited NSE:BOHRAIND	0.009x
Aclarion Inc NASDAQ:ACON	-0.093x
Ngenic AB ST:NGENIC	0.592x

Annual Cash Flow Conversion Efficiency for CanadaBis Capital Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of CanadaBis Capital Inc from 2016 to 2025. View CanadaBis Capital Inc share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-07-31	CA$7.92 Million ≈ $5.73 Million	CA$-3.20 Million ≈ $-2.31 Million	-0.403x	-1066.36%
2024-07-31	CA$7.41 Million ≈ $5.36 Million	CA$-256.31K ≈ $-185.41K	-0.035x	-104.58%
2023-07-31	CA$7.34 Million ≈ $5.31 Million	CA$5.55 Million ≈ $4.01 Million	0.755x	+2503.59%
2022-07-31	CA$2.63 Million ≈ $1.91 Million	CA$-82.77K ≈ $-59.88K	-0.031x	+96.83%
2021-07-31	CA$1.82 Million ≈ $1.32 Million	CA$-1.81 Million ≈ $-1.31 Million	-0.992x	+5.88%
2020-07-31	CA$3.43 Million ≈ $2.48 Million	CA$-3.62 Million ≈ $-2.62 Million	-1.054x	-77.49%
2019-07-31	CA$2.85 Million ≈ $2.06 Million	CA$-1.69 Million ≈ $-1.23 Million	-0.594x	-1993.66%
2018-07-31	CA$317.23K ≈ $229.48K	CA$9.95K ≈ $7.20K	0.031x	+120.18%
2017-07-31	CA$455.59K ≈ $329.57K	CA$-70.81K ≈ $-51.22K	-0.155x	--
2016-07-31	CA$150.00K ≈ $108.51K	CA$0.00 ≈ $0.00	0.000x	--

About CanadaBis Capital Inc

V:CANB Canada Drug Manufacturers - Specialty & Generic

Market Cap

$1.53 Million

CA$2.12 Million CAD

Market Cap Rank

#30357 Global

#1525 in Canada

Share Price

CA$0.02

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.05

All Time High

CA$0.55